Targeting human liver cancer cells with lactobionic acid-G(4)-PAMAM-FITC sorafenib loaded dendrimers.
Iacobazzi RM, Porcelli L, Lopedota AA, Laquintana V, Lopalco A, Cutrignelli A, Altamura E, Di Fonte R, Azzariti A, Franco M, Denora N.
Iacobazzi RM, et al. Among authors: di fonte r.
Int J Pharm. 2017 Aug 7;528(1-2):485-497. doi: 10.1016/j.ijpharm.2017.06.049. Epub 2017 Jun 15.
Int J Pharm. 2017.
PMID: 28624661